puts it in his awesome blog post, squalane's main things are " emolliency , surface occlusion, and TEWL prevention all with extreme cosmetic elegance "
In 2023, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies, and there is insufficient evidence regarding potential harm to humans
Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antago nists: study using the Spanish registry of adverse events of biologica therapies in rheumatic diseases
The human copper-binding peptide GHK-Cu (glycyl-l-histidyl-l-lysine) is a naturally occurring tri-peptide found in human plasma and released from tissues during injury
Whether you're working on novel obesity treatments, diabetes medications, or other pharmaceutical innovations, our team is ready to assist you